Journal of gastroenterology and hepatology · 2026
Involvement of Periostin in Intestinal Fibrosis Associated With Crohn's Disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Takedomi Hironobu, Nunomura Satoshi, Nanri Yasuhiro, Honda Yuko, Okada Takashi, Tun Xin, Sadashima Kento, Akutagawa Takashi, Tsuruoka Nanae, Sakata Yasuhisa, Conway Simon J, Kawaguchi Atsushi, Aishima Shinichi, Esaki Motohiro, Izuhara Kenji
Аннотация
BACKGROUND AND AIM: Crohn's disease (CD) is a chronic inflammatory bowel disease characterized by excessive intestinal fibrosis. We previously demonstrated that periostin is highly expressed in various fibrosis-related diseases and is important in the development of fibrosis. In this study, we aimed to investigate the role of periostin in the pathogenesis of CD.
METHODS: We evaluated periostin expression in the terminal ileum of CD patients. We examined serum periostin levels in 75 CD patients and 150 healthy controls. We applied periostin-deficient (PNKO) and wild-type (WT) mice to a mouse model mimicking CD induced by repeated intrarectal administration of 2,4,6-trinitrobenzene sulfonic acid (TNBS).
RESULTS: Periostin was highly expressed in the stenotic areas of CD patients compared with controls, correlated with the severity of intestinal fibrosis. Serum periostin levels were significantly higher in CD patients than in healthy controls (88.5 ng/mL vs. 65.5 ng/mL; p < 0.01). In the mice with TNBS-induced colitis, periostin was highly expressed transmurally in the intestines, similar to CD patients. Fibrosis scores, collagen deposition, and phosphorylation of Smad3 were significantly increased in WT mice, whereas these were attenuated in PNKO mice.
CONCLUSIONS: CD patients showed significantly high expression of periostin in both tissues and serum. Taken together with its important role in the underlying mechanism of fibrosis in the TNBS-treated mice, periostin is involved in the development of fibrosis in CD patients.
METHODS: We evaluated periostin expression in the terminal ileum of CD patients. We examined serum periostin levels in 75 CD patients and 150 healthy controls. We applied periostin-deficient (PNKO) and wild-type (WT) mice to a mouse model mimicking CD induced by repeated intrarectal administration of 2,4,6-trinitrobenzene sulfonic acid (TNBS).
RESULTS: Periostin was highly expressed in the stenotic areas of CD patients compared with controls, correlated with the severity of intestinal fibrosis. Serum periostin levels were significantly higher in CD patients than in healthy controls (88.5 ng/mL vs. 65.5 ng/mL; p < 0.01). In the mice with TNBS-induced colitis, periostin was highly expressed transmurally in the intestines, similar to CD patients. Fibrosis scores, collagen deposition, and phosphorylation of Smad3 were significantly increased in WT mice, whereas these were attenuated in PNKO mice.
CONCLUSIONS: CD patients showed significantly high expression of periostin in both tissues and serum. Taken together with its important role in the underlying mechanism of fibrosis in the TNBS-treated mice, periostin is involved in the development of fibrosis in CD patients.